Drug Shortage Report for ROTATEQ
| Report ID | 134639 |
| Drug Identification Number | 02284413 |
| Brand name | ROTATEQ |
| Common or Proper name | rotavirus vaccine, live, oral, pentavalent oral solution |
| Company Name | MERCK CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | HUMAN-BOVINE ROTAVIRUS REASSORTANT TYPE G1 HUMAN-BOVINE ROTAVIRUS REASSORTANT TYPE G2 HUMAN-BOVINE ROTAVIRUS REASSORTANT TYPE G3 HUMAN-BOVINE ROTAVIRUS REASSORTANT TYPE G4 HUMAN-BOVINE ROTAVIRUS REASSORTANT TYPE P1 |
| Strength(s) | 2210000UNIT 2840000UNIT 2220000UNIT 2040000UNIT 2290000UNIT |
| Dosage form(s) | SOLUTION |
| Route of administration | ORAL ORAL |
| Packaging size | 10 X 1 DOSE VIAL |
| ATC code | J07BH |
| ATC description | VIRAL VACCINES |
| Reason for shortage | Delay in shipping of the drug. |
| Anticipated start date | 2021-04-09 |
| Actual start date | |
| Estimated end date | 2021-04-16 |
| Actual end date | 2021-04-07 |
| Shortage status | Avoided shortage |
| Updated date | 2021-04-07 |
| Company comments | Format ROTATEQ 2ML 1DOSE TUBE CAN remains available. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 16750 ROUTE TRANSCANADIENNE KIRKLAND, QUEBEC CANADA H9H 4M7 |
| Company contact information | 1-800-567-2594 medinfocanada@merck.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v7 | 2021-04-07 | English | Compare |
| v6 | 2021-03-31 | English | Compare |
| v5 | 2021-03-22 | English | Compare |
| v4 | 2021-02-24 | English | Compare |
| v3 | 2021-02-24 | French | Compare |
| v2 | 2021-02-24 | English | Compare |
| v1 | 2021-02-24 | English | Compare |
Showing 1 to 7 of 7